FindTrial
Sign In

Medication is better for diabetic people with depression compared to counselling.

Randomized control trial to compare the efficacy of anti-depressant medication versus diabetic specific cognitive behavioral therapy on glycemic control and quality of life in patients with Type 2 Diabetes Mellitus and co morbid depression in central Karnataka, India.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009250
Enrollment
72
Registered
2017-08-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Type 2 Diabetes Mellitus

Interventions

Intervention1: Anti depression medication (ADM): Once-a-day scheduled administration of ADM Escitalopram starting at 5 mg will be administered. Control Intervention1: Cognitive Behavior therapy (CBT):

Sponsors

Rajiv Gandhi University of Health Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Living with type 2 diabetes mellitus for at least 1 year

Exclusion criteria

Exclusion criteria: Not diagnosed or on treatment for any psychiatric treatment

Design outcomes

Primary

MeasureTime frame
â?? improvement of glycemic control defined as decrease of at least 1% of HbA1c value from baseline value to the end of the study.Timepoint: At the end of 9 months of trial—

Secondary

MeasureTime frame
1. Improvement of depression according to MADRS scores at least by 50%. 2. Improvement of Health related quality of life i.e., change in mean score in generic HRQOL from baseline to the end of trial as assessed per SF-36 Timepoint: At the end of 9 months of trial—

Countries

India

Contacts

Public ContactAnurupa MS

JJM Medical College

anuashokrag@gmail.com9844034748

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026